ArticleJACC. Case reports2026
Acute Coronary Syndrome in a Master's Athlete and No Modifiable Risk: Gaps in Return-to-Play Guidance.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute coronary syndrome (ACS) is the leading cause of sudden cardiac death in master's athletes. Current return-to-competition guidelines recommend cardiac rehabilitation and risk factor modification, but do not address athletes lacking modifiable risk factors or revascularization options. CASE SUMMARY: A 46-year-old male competitive runner developed ACS from plaque rupture following a marathon. Stenting was deferred due to malapposition risk with large-caliber coronaries. He completed cardiac rehabilitation and was cleared to return to competition at 6 months. WHY BEYOND THE GUIDELINES?: This patient had no modifiable risk factors and was not a candidate for revascularization, leaving his pre- and postevent cardiovascular risk unchanged despite meeting guideline criteria for return to competition. DISCUSSION: Conventional risk stratification tools, including risk calculators and coronary calcium scoring, are less accurate in master's athletes, creating a gap in counseling unrevascularized patients. TAKE-HOME MESSAGE: Master's athletes with ACS, no modifiable risk factors, and unrevascularized lesions require improved risk stratification tools and further research to guide return-to-competition counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.